Soliris Concentrate for Solution for Infusion 300mg/vial
Product details
Registration number: SIN14226P
Classification: Prescription Only
Active ingredients: Eculizumab
Strength: 300 mg / vial
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: L04AJ01
HSA approval date: 12 September 2012
Manufacturer(s):
- Alexion Pharma International Operations Limited (AAMF)
- PATHEON ITALIA S.P.A
Manufacturing country/countries: ITALY; IRELAND
What are the HSA registration number and classification for Soliris Concentrate for Solution for Infusion 300mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14226P
Classification: Prescription Only
What active ingredients and strength are recorded for Soliris Concentrate for Solution for Infusion 300mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Eculizumab
Strength: 300 mg / vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Soliris Concentrate for Solution for Infusion 300mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Soliris Concentrate for Solution for Infusion 300mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for Soliris Concentrate for Solution for Infusion 300mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Alexion Pharma International Operations Limited (AAMF)
- PATHEON ITALIA S.P.A
Manufacturing country/countries: ITALY; IRELAND
Where can I look up Soliris Concentrate for Solution for Infusion 300mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14226P or the exact product name Soliris Concentrate for Solution for Infusion 300mg/vial. The general register link does not preselect this product.
What are the source dates for this Soliris Concentrate for Solution for Infusion 300mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Soliris Concentrate for Solution for Infusion 300mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14226P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)